Bayer's BR and Butyl Units Receive QS-9000 Certification
29 September 1999
Bayer's BR and Butyl Units Receive QS-9000 Certification
PITTSBURGH--(AutomotiveWire)--Sept. 28, 1999--Bayer Inc.'s BR and butyl manufacturing units in Sarnia, Ontario, have received QS-9000 certification, becoming among the few rubber manufacturing facilities in the world to receive the coveted certification -- just one year after Bayer's NBR manufacturing unit in Sarnia became the first."We're committed to continually enhancing our business processes -- in terms of product quality, customer service and taking a proactive approach to meeting our customers' needs," said Dennis Loucks, Manufacturing Manager at the Sarnia plant. "We led the way toward QS-9000 certification for a rubber manufacturer with our NBR unit, and now we're continuing to sharpen Bayer's competitive edge with QS-9000 certification of our BR and butyl units."
The QS-9000 certification, third edition, was awarded to Bayer Inc.'s BR and butyl facilities after an intensive audit in June of the units' manufacturing processes, strategic business planning and customer satisfaction. The units officially received the certification in August. During the audit, Bayer's NBR unit in Sarnia, which was the first rubber manufacturing facility worldwide to receive QS-9000 certification, second edition, received the updated, more stringent third edition certification.
Bayer Inc. is a research-based company with major businesses in life sciences and chemicals. Headquartered in Toronto, Ontario, with a major manufacturing site in Sarnia, Ontario, Bayer Inc. employs more than 2,200.
Bayer Corporation's Therban(R) HNBR manufacturing facility in Orange, Texas, also recently received QS-9000 certification, becoming the only HNBR unit to achieve the standard. In addition, Bayer Corporation is currently pursuing QS-9000 certification for its BR and Buna EP facilities in Orange and its Rubber Chemicals facility in Bushy Park, South Carolina.
Bayer Corporation is a research-based company with major businesses in health care and life sciences and chemicals. The company had 1998 sales of $8.1 billion and employs more than 23,000 people. Bayer Corporation is investing $15 billion in capital expenditures and research and development from 1995 through the year 2004. 1999 capital investment and R&D expenditures are projected to total $1.6 billion. Bayer Corporation, with headquarters in Pittsburgh, is a member of the worldwide Bayer Group, a $31 billion international life sciences, polymers and specialty chemicals group based in Leverkusen, Germany.